me with, one of thle ading companies in the business, recently hel an eventn new york city and meg tyrrell went to check it out foror us. >> repter: new yorker deborah wants to learn more about her where she came from. >> my background is splendid i had. i'm curus as to what my full background, my ancestry is. >> an instagram post about an event for 23 and me caught her attention. the company just onem of now offering direct to consumer genetic testsar in at exploding in recent years. 23 and me opened up a pop up new york city to explain the informationuthey give a everything from how you sleep to how your body processes caffeine with to gluten, lack toes, to even how the muscles work. a >> it' example of the category's massive increase in advertising. up 63% in the first half of he year. driven by the largest companies, 23 and me and ancestry. the market for consumer genetic testsop could$6 billion according to ever core isi but some experts a the growth and promising supplied or explicit about what sots accomplish. >> the benefit for cancer carrier testing, these are solid. unfortunately

meg tyrrell has been listening to the call at headquarters. >> much of the focus of the call was theof the legalization of recreational mau. that started a month ago so it didn't impact the quarter which saw wider adjusted loss of 8 crepts is a share. the cfo saying on the call just now that demand is so strong that supply is a challenge. >> with the imbalance we have today with mar demand than supply, everything is selling out. it's really hard to tell what consumers are going to prefer longer term. consumers are limited on form factors. as vape cartridges and edibles and beverages hit the market within the next year, we'll see what consumers want. this is really kind of short-term high demand for every product the consumer can get in re hands on. >> and of course will also a focus on the u.s. and recent political changes. the tilray ceo referred to jeff sessions on the call as a drug war dinosaur and on an interview he says the u.s. is behind other countries when it comes to marijuana. but he expressed optimism for this market focusing on another politician and an important house r

pharma gained 3.5%. >> meg tyrrell back at health cares. where do you go, guy in this sideways because drug price something bipartisan issue. >> bipartisan issue but president trump tweets about drugs in the spring. why is it pfizer is gone up in a straight line. the biggest move in pfe in the last decade orz. although the rhetoric is out there the stocks say something else eli lilly is one if you look eli lilly down 3.5, 4% line in the sand through the fall held there. here we are illustrate critical it holds there pfizer although it hasn't gone up hasn't gone down. i think pfizer is building a base for the next leg higher >> they all made the same move it's coincident with a rotation almove this is an afflictle story as much as that seems anti-thet cal to what's going on i don't think it matters if the market struggles at higher multiples these outperform that's why i think they outperformed. >> for biohe can. >> big pharma that's on pig pharma. >> talking about aca overturned either way it's a win for hmos, drug companies if you become m

and meg tyrrell was there. >> reporter: new yorker debra want to learn more about where she came from>> my background is pretty splendid i'm kinus of cur as to what my full background -- my ancestry. >> so an instaam post about an even for 23 and me caught her attention. the company is just onef many now offering the direct to consumer jenn et etic tests in a recent hat exploded in years. >> 23 and me opened a pop-up in new york city to explain the information thebo give a everything from how you sleep to how your body processes caffeine to gluten, lactose to even how muscles work. >> it's an example of the tegory's massive increase in advertising up 63% in the first half othe year. driven by largestpr company ocess 23 and me and ancestry. the market could top $6 billion according to ever core isi but some experts are concerned and promising implied or explicit about what tests can accomplish. >> the benefit for cancer carrier testing, these are solid. unfortunately we h all the other you know -- 90% of the field is essentially very questionable. >> one independent company promises to